Skinbiotherapeutics Share Discussion Threads

[slartybartfaster] 13/5/2017 12:07

Whats with the obsession over the share price right now? Right now is the time you want it to stay low while you accumulate funds to accumulate more stock. Unless your elrico ripping off a carpet every other day.

[love it] 13/5/2017 01:35

No big sales yesterday (Friday) they had every chance so maybe seller/s out
and price can get back to 12p for starters.

[slartybartfaster] 12/5/2017 20:46

Me sir, no not me. Was it the £300 then :))

[elrico] 12/5/2017 19:08

Someone's full of mischief today.

[slartybartfaster] 12/5/2017 17:12

was that your £275 elrico :))

[elrico] 12/5/2017 16:32

Nice bounce....myself and Parob played our part today :)

[trotterstrading] 12/5/2017 16:09

The beauty of SBTX product is that it's not actually a bacterial strain that's the active ingredient, rather it derived from Bacteria. This means they sidestep any 'concerns' with adding bacterium to creams

[love it] 12/5/2017 16:05

elrico

Think the 50,000 did the damage. Anybody know what the mm's are quoting at 10p ?

[parob] 12/5/2017 16:03

Glad I grabbed some when I did! Wonder if we've seen the bottom this week.

[elrico] 12/5/2017 16:03

Yet there's no problem buying 50,000.

[love it] 12/5/2017 16:01

Yes they have pulled the online buy limits. Maybe they will open them if it goes
to 10.5p offer

[bigboots] 12/5/2017 15:55

no stock out there to buy....

[love it] 12/5/2017 15:25

9.95p paid so online bid up to 9.575p from 9.44p

[parob] 12/5/2017 15:25

Another 33K for me. Would have liked 9.75p but .2p won't make much difference in the long run and didn't want to risk not seeing this price again! Don't think we'll have to wait too long for the first piece of news now - as we floated over a month ago.

[love it] 12/5/2017 13:13

Some nibbles, a nice Friday afternoon bounce from the low would be welcome.

[ibug] 12/5/2017 11:02

All the major corporates in the skin care industry are clearly very interested in the microbiome of the skin and SBTX is therefore very well placed to be able to commercialize the tech as they approach the clinical trial stage of development.

[slartybartfaster] 12/5/2017 10:52

Johnson & Johnson have been working with Uni of Manc since 2014 before opti bought the ip. It would be nice to see this develop into our first product. At the moment it sounds like some companies are rushing products out without backing them up with science. SBTX will back their products up with proof of science first. the same principal as parent company, opti.

[slartybartfaster] 12/5/2017 10:47

Quite possibly the dumping has finished for now. Now we we wait for news to encourage buying. Until then we have a period of consolidation?

[ibug] 12/5/2017 10:27

VERY ENLIGHTENING ARTICLE this shows the levels of interest growing in the sector and the potential of the SBTX skin clinical trials coming our way soon:

Cosmetic makers harness microbiome to help treat skin conditions.May 10, 2017

Cosmetic companies have started developing and selling products designed to harness the skin microbiome to help treat a range of skin conditions from acne to eczema. Skeptics, however, warn that touting such an approach is premature because scientists are still working to understand the bacteria that live on our skin and interact with it. The cover story in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, scopes out the scene.

Marc S. Reisch, a senior correspondent at C&EN, reports that cosmetic firms, large and small, are increasingly interested in how the microbiome affects skin health. To see if they can bottle some of its potential benefits, they're researching skin bacteria and active ingredients to promote helpful microbes and discourage harmful ones. However, skeptics caution that scientists don't yet have a baseline picture of what a healthy skin microbiome would look like, much less know how to achieve a healthy bacterial community.

Undeterred by the limited body of skin microbiome knowledge, at least a couple of companies have already marketed bacteria-based product lines. Yun Probiotherapy says its line incorporates "friendly" bacteria to help correct skin microbe imbalances. AOBiome based its product on results from a study examining why horses roll in the dirt. They found that bacteria in the dirt produce compounds that help regulate inflammation and that could be beneficial to skin. Cosmetic heavyweights, including Johnson & Johnson, Procter & Gamble and L'Oréal, are also developing microbiome-based products.

[love it] 12/5/2017 10:23

Perhaps buyers are waiting to see if it turns blue first just incase a big sell comes along. If it went 9.5p bid and blue I can see a rush to get in.

[ibug] 12/5/2017 10:03

Here is the latest edition of Microbiome...well worth reading imo.

[moneytree1] 12/5/2017 07:56

don't see the problem why ppl are worrying so much about the price.

everyones long term holders right?

so why wouldn't you all want it to go as low as possible to pick up as cheap as possible stock?

I couldn't give a toss if it went below 9p

[scotty1] 12/5/2017 07:49

blimey don't you know that means nothing as all MMs wont be showing yet,wally

[moneytree1] 12/5/2017 07:41

blimey, 7p on the bid premarket....
loveit wont be happy